Can optical evaluation distinguish between T1a and T1b esophageal adenocarcinoma: an international expert interobserver agreement study

Expert Barrett's endoscopists could reliably differentiate T1a/T1b esophageal adenocarcinoma from HGD. Despite fair-to-moderate agreement for T staging, T1b disease could not be reliably distinguished from T1a disease. This may impact clinical decision making and selection of endoscopic techniques.

Authors

Institutions

Publication Details

Journal
Endoscopy
Published
2024-08-21
DOI
https://doi.org/10.1055/a-2399-1401
Citations
11
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
6.30

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Can optical evaluation distinguish between T1a and T1b esophageal adenocarcinoma: an international expert interobserver agreement study

Christopher Teshima, Michael B. Wallace, Mário Jorge Dinis-Ribeiro, Torsten Beyna et al.
11 citations
Endoscopy
Esophageal Cancer Research and Treatment
6.30
article

Can optical evaluation distinguish between T1a and T1b esophageal adenocarcinoma: an international expert interobserver agreement study

Christopher Teshima, Michael B. Wallace, Mário Jorge Dinis-Ribeiro, Torsten Beyna, Alessandro Repici, Roos E. Pouw, Francesco Vito Mandarino, Eric Y.T. Lee, Andrew C.F. Taylor, Sunil Gupta, Luke F. Hourigan, Helmut Messmann, Thomas Rösch, Arnaud Lemmers, Jeffrey D. Mosko, Peter D. Siersema, Nicholas G. Burgess, Oliver Pech, Neal Shahidi, Raf Bisschops, Irving Waxman, Krish Ragunath, Prateek Sharma, Gregory Haber, Michael J. Bourke
article en
11 citations

Abstract

Expert Barrett's endoscopists could reliably differentiate T1a/T1b esophageal adenocarcinoma from HGD. Despite fair-to-moderate agreement for T staging, T1b disease could not be reliably distinguished from T1a disease. This may impact clinical decision making and selection of endoscopic techniques.

EndoscopyVol. 57(03)
Rush University Medical Center (US), The University of Sydney (AU), St. Michael's Hospital (CA), Humanitas University (IT), University of Kansas (US), Universität Hamburg (DE), Curtin University (AU), Royal Perth Hospital (AU), Jacksonville College (US), Princess Alexandra Hospital (AU), Erasmus MC (NL), University Hospital Augsburg (DE), Erasmus Hospital (BE), WinnMed (US), Westmead Hospital (AU), NYU Langone Health (US), St Vincent's Hospital Melbourne (AU), Instituto Português de Oncologia Francisco Gentil (PT), University Medical Center Hamburg-Eppendorf (DE), Evangelisches Krankenhaus Düsseldorf (DE), Mayo Clinic in Florida (US), Amsterdam University Medical Centers (NL), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Kansas City VA Medical Center (US), University of Regensburg (DE), KU Leuven (BE)
Boston Scientific Corporation, Cook Medical, Ironwood Pharmaceuticals, Incorporated, Verily Life Sciences, Norgine
Partnerships for the goals
Openalex Percentile: Top 3%
Esophageal Cancer Research and Treatment
6.30
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.